To all my readers and friends. Happy Thanksgiving! Remember that the drugs we make and market allow a lot of families to gather for this festive day around the dinner table. However, there will be a lot of empty chairs as well, which means we still have a lot of work to do.
KEY TAKEAWAY: The stock price of Eli Lilly dropped suddenly on Tuesday after Sen. Bernie Sanders criticized the rising price of the company’s insulin drug Humalog on Twitter. Drug companies are going to hear a lot more about drug pricing which in turn is going to put pressure on everything pharma does. Continue reading
KEY TAKEAWAY: The biggest reason for the projected “flat spending” in DTD advertising is due to the simple fact that there aren’t going to be and new products that are intended to be targeted towards big audiences. Drugs in development are specialty drugs and as thus they will require targeted marketing to reach their audience. Continue reading
KEY TAKEAWAY: , according to Equilar, a California firm that researches and analyzes executive compensation. Median compensation for all CEOs in the study, which looked at pay packages of 341 executives at S&P 500 companies across multiple sectors in 2015, was $10.8 million. The increase in healthcare executive pay from 2014 to 2015 was also greater than in other sectors. Healthcare CEO pay rose 7 percent last year over the amount in 2014, while the comparable median pay increase for all industries was 4.5 percent. Continue reading
It’s now estimated as many as one in five people in this country will die from obesity-related disease. What’s significant about that number is that it’s three times higher than previous estimates. In an eye-opening new report, researchers studied men and women between the ages of 40 to 85 over a 20-year period. they found that obesity was likely responsible for about 18% of deaths during that time, one out of five americans. Obesity is going to increasingly shape the mortality levels in the united states as we move forward. Continue reading
KEY TAKEAWAY: An innovative and disruptive digital agency, Greater Than One, have found a way to successfully address the problems of patient engagement by thinking outside the box. Continue reading
KEY TAKEAWAY: Genetech,Roche, paid a fine of $68 million for illegal marketing of a brand that has billions of dollars in sales. This leads to a question of “why?”. Was it political influence? Continue reading